This bill — the Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019 — would extend a number of provisions within the Medicaid program that serve to make the program more effective. A breakdown of the extensions can be found below.
Money Follows the Program Rebalancing Demonstration (MFP)
This bill would extend the Money Follows the Person Rebalancing Demonstration (MFP), which helps states rebalance their Medicaid long-term care systems by transitioning people with chronic conditions and disabilities into community-based care, through FY 2024. It’d also extend research and evaluation requirements for MFP through FY 2024 and clarify the process by which states apply for the MFP by requiring each state to include a description of their planned use of MFP funds and program evaluation plans in their applications.
Additionally, this bill would require a report to the president and Congress describing findings and conclusions on best practices for MFP implementation. Finally, it’d require a Medicaid and CHIP Payment and Access Commission (MACPAC) report to Congress on the Commission’s position on the Home and Community Based Services (HCBS) Final Rule published on January 16, 2014.
State Medicaid Fraud and Abuse Control Units’ Authority to Investigate and Prosecute Medicaid Patient Abuse and Neglect
This bill would clarify that state Medicaid fraud and abuse control units are authorized to investigate abuse and neglect of Medicaid patients in board and care facilities, as well as patients receiving Medicaid-funded care in noninstitutional settings.
Protection for Medicaid Recipients Against Spousal Impoverishment
This bill would extend spousal impoverishment protections for seniors who receive long-term care in their homes or community settings through March 31, 2024.
Community Mental Health Services Demonstration Program
This bill would extend the Community Mental Health Services Demonstration Program through December 21, 2021 and require a report to Congress recommending whether the program should be continued, expanded, modified or terminated by June 30, 2021.
Inappropriately Low Rebates Under Medicaid Drug Rebate Program
This bill would prohibit drug manufacturers from blending the average manufacturer price of branded drugs and their authorized generics for the purposes of determining Medicaid rebates. It’d also eliminate drug manufacturers from being defined as drug wholesalers.
Medicaid Improvement FundFinally, this bill would appropriate $45.5 million for the Medicaid Improvement Fund.